Dawn O'Shea -

1 month ago | medicalindependent.ie | Dawn O'Shea - |Dawn O'Shea |Simon Bull |Priscilla Lynch

Reference: April 2025 | Issue 4 | Vol 11 | Page 36 Beaumont RCSI Cancer Centre and the Irish Cancer Society has launched a first-of-its-kind pilot initiative for earlier diagnosis of lung cancer. Lung Health Check will provide lung screening in the community for individuals between 55 and 74 years of age at high risk of lung cancer.

1 month ago | medicalindependent.ie | Dawn O'Shea - |Dawn O'Shea |Simon Bull |Priscilla Lynch

Reference: April 2025 | Issue 4 | Vol 11 | Page 42 Research led by the Centre for Experimental Pathogen Host Research (CEPHR) at University College Dublin has found that memory B cells are a more accurate indication of Covid-19 vaccine protection than antibody titres or T-cell responses. A clear immune correlate of protection from SARS-CoV-2 infection has been lacking.

1 month ago | medicalindependent.ie | Dawn O'Shea - |Dawn O'Shea |Priscilla Lynch |J Whooley

Reference: April 2025 | Issue 4 | Vol 11 | Page 41 Pembrolizumab monotherapy is an established front-line treatment for advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) tumour proportion score (TPS) ≥50 per cent. However, real-world data on its long-term efficacy remain sparse.

1 month ago | medicalindependent.ie | Dawn O'Shea - |Dawn O'Shea |Simon Bull |Priscilla Lynch

Reference: April 2025 | Issue 4 | Vol 11 | Page 43 New findings from the European Thoracic Oncology Platform (ETOP) Mesoscape project suggest the immunoregulatory protein CD276 (B7-H3) holds potential as a therapeutic target in pleural mesothelioma (PM).